These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5714231)

  • 21. [On the effect of various cardiac drugs on the connective tissue].
    Junge-Hülsing G; Schmitt G; Wagner H
    Med Welt; 1967 Dec; 49():2961-2 passim. PubMed ID: 4238933
    [No Abstract]   [Full Text] [Related]  

  • 22. [Isoptin studies on normal subjects and patients with coronary disease].
    Knoch G; Schlepper M; Witzleb E
    Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of Intenkordin].
    Markiewicz M; Korolko A; Hruczkowska E
    Pol Tyg Lek; 1972 May; 27(21):796-8. PubMed ID: 5028365
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recent data on coronary dilators].
    Duchêne-Marullaz P; Lavarenne J
    Actual Pharmacol (Paris); 1968; 21():65-116. PubMed ID: 4890107
    [No Abstract]   [Full Text] [Related]  

  • 25. [Controlled clinical testing of the coronary agent Carduben].
    Wettengel R
    Med Welt; 1973 Feb; 24(7):253. PubMed ID: 4731694
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intensain treatment of acute coronary insufficiency].
    Votchal BE; Lozinskiĭ LG
    Kardiologiia; 1970 Dec; 10(12):29-34. PubMed ID: 5507772
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experimentation with Cardiocap in subjects with coronary disease with coronary insufficiency].
    Marignani A; Martelli A; Piana G
    Minerva Cardioangiol; 1973 Sep; 21(9):629-35. PubMed ID: 4745005
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical trial of sedo-intensain in the treatment of coronary angor].
    Steenhouwer B
    Lille Med; 1968 Oct; ():Suppl 6:815+. PubMed ID: 5748100
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experiences with the coronary drug carduben].
    Thönelt K
    Z Allgemeinmed; 1970 Nov; 46(32):1618-21. PubMed ID: 5512832
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K; Wcislo W
    Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
    [No Abstract]   [Full Text] [Related]  

  • 31. Coronary arteriograms before and after long-term oral administration of coronary dilators in man.
    Düx A; Schaede A
    Ger Med Mon; 1969 Oct; 14(10):473-5. PubMed ID: 5364342
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of coronary dilatators on strophanthin toxicity].
    Mentz P; Förster W
    Acta Biol Med Ger; 1972; 28(5):839-43. PubMed ID: 5074149
    [No Abstract]   [Full Text] [Related]  

  • 33. [Importance of carbocromen in the treatment of anginal pain].
    Baledent M; Dutrieux JP; Marguery J; Delmaire M
    Lille Med; 1968 Oct; ():Suppl 6:808+. PubMed ID: 5748099
    [No Abstract]   [Full Text] [Related]  

  • 34. [The coronary dilatator effect of various reference drugs].
    Duchene-Marullaz P; Cosnier D; Grimald J
    Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the problem of drug-induced increase of coronary blood circulation in humans].
    Hilger HH; Behrenbeck DW; Hellwig H; Wagner J; Thelen M
    Verh Dtsch Ges Inn Med; 1968; 74():574-8. PubMed ID: 5714385
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic and prophylactic effectiveness of carbochromen in experimental myocardial infarct].
    Kipshidze NN; Kikawa GM
    Acta Cardiol; 1974; 29(3):185-202. PubMed ID: 4135425
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical research on the action of dipyridamole administered alone or with benziodarone in coronary insufficiency].
    Rădulescu M
    Med Interna (Bucur); 1965 Oct; 17(10):1225-9. PubMed ID: 5862277
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of cardio- and vasoactive substances on phosphodiesterase activity].
    Pöch G; Juan H; Kukovetz WR
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):293-4. PubMed ID: 4310614
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of Visnadine in chronic degenerative myocardial lesions].
    Bargheer R; Fiegel G; Saito S; Guttmann W
    Arzneimittelforschung; 1967 Mar; 17(3):288-90. PubMed ID: 5631219
    [No Abstract]   [Full Text] [Related]  

  • 40. [Site of action of the coronary medication, carbochromen].
    Alfes H; Schraven E; Möllmann H; Ostrowski J; Bigalke G; Nitz RE
    Brux Med; 1974 May; 54(5):303-8. PubMed ID: 4214587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.